A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue

被引：0
|
作者：
Vladimir Tolmachev
Irina Velikyan
Mattias Sandström
Anna Orlova
机构：
[1] Uppsala University,Division of Biomedical Radiation Sciences, Rudbeck Laboratory
[2] Uppsala University,Division of Nuclear Medicine, Department of Medical Sciences
[3] Uppsala University,Department of Biochemistry and Organic Chemistry
[4] GEMS PET Systems,Uppsala Applied Science Lab
[5] GE Healthcare,Hospital Physics, Department of Oncology
[6] Uppsala University Hospital,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2010年 / 37卷
关键词：
Affibody molecule; HER2; Ga; Tumour targeting; Molecular imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1356 / 1367
页数：11
相关论文
共 20 条
  • [1] A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue
    Tolmachev, Vladimir
    Velikyan, Irina
    Sandstrom, Mattias
    Orlova, Anna
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (07) : 1356 - 1367
  • [2] Direct comparison of 111In-labelled two-helix and three-helix Affibody molecules for in vivo molecular imaging
    Rosik, Daniel
    Orlova, Anna
    Malmberg, Jennie
    Altai, Mohamed
    Varasteh, Zohreh
    Sandstrom, Mattias
    Karlstrom, Amelie Eriksson
    Tolmachev, Vladimir
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (04) : 693 - 702
  • [3] FASTlab Radiosynthesis of the 18F-labelled HER2-binding Affibody molecule [18F]GE-226
    Iveson, Peter B.
    Glaser, Matthias
    Indrevoll, Bard
    Shales, Jonathan
    Mantzilas, Dimitrios
    Omtvedt, Lone
    Luthra, Sajinder K.
    Hiscock, Duncan
    Grigg, Julian
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 (14) : 925 - 932
  • [4] 68Ga-DOTA-Affibody molecule for in vivo assessment of HER2/neu expression with PET
    Kramer-Marek, Gabriela
    Shenoy, Nalini
    Seidel, Jurgen
    Griffiths, Gary L.
    Choyke, Peter
    Capala, Jacek
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (11) : 1967 - 1976
  • [5] 68Ga-DOTA-Affibody molecule for in vivo assessment of HER2/neu expression with PET
    Gabriela Kramer-Marek
    Nalini Shenoy
    Jurgen Seidel
    Gary L. Griffiths
    Peter Choyke
    Jacek Capala
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1967 - 1976
  • [6] Evaluation of backbone-cyclized HER2-binding 2-helix Affibody molecule for In Vivo molecular imaging
    Honarvar, Hadis
    Jokilaakso, Nima
    Andersson, Karl
    Malmberg, Jennie
    Rosik, Daniel
    Orlova, Anna
    Karlstrom, Amelie Eriksson
    Tolmachev, Vladimir
    Jarver, Peter
    NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (03) : 378 - 386
  • [7] 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression
    Clemens Decristoforo
    Ignacio Hernandez Gonzalez
    Janette Carlsen
    Marco Rupprich
    Marc Huisman
    Irene Virgolini
    Hans-Jürgen Wester
    Roland Haubner
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1507 - 1515
  • [8] 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression
    Decristoforo, Clemens
    Gonzalez, Ignacio Hernandez
    Carlsen, Janette
    Rupprich, Marco
    Huisman, Marc
    Virgolini, Irene
    Wester, Hans-Juergen
    Haubner, Roland
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (08) : 1507 - 1515
  • [9] Diagnostic HER2-binding radiopharmaceutical, [68Ga]Ga-ABY-025, for routine clinical use in breast cancer patients
    Velikyan, Irina
    Schweighoefer, Philip
    Feldwisch, Joachim
    Seemann, Johanna
    Frejd, Fredrik Y.
    Lindman, Henrik
    Soerensen, Jens
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 9 (01): : 12 - 23
  • [10] Application of a Novel 68Ga-HER2 Affibody PET/CT Imaging in Breast Cancer Patients
    Miao, Haitao
    Sun, Yuyun
    Jin, Yizi
    Hu, Xichun
    Song, Shaoli
    Zhang, Jian
    FRONTIERS IN ONCOLOGY, 2022, 12
12